QA: Seelos Therapeutics INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001017491_2014_Seelos_Therapeutics_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001017491, Seelos Therapeutics INC

  xvar xval
0 AssetsCurrent 22,264,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 955,000
3 remainder_Assets 91,000
4 LiabilitiesCurrent 11,760,000
5 LiabilitiesNoncurrent 91,000
6 remainder_Liabilities 487,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,554,000
9 ResearchAndDevelopmentExpense 5,123,000
10 remainder_Expenses 1,201,000
11 remainder_Revenues 2,511,000
12 remainder_NetIncome 429,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 23,310,000
1 Liabilities 12,338,000
2 Expenses 19,878,000
3 Revenues 2,511,000
4 StockholdersEquity 10,972,000
5 NetIncome -16,938,000
6 ComprehensiveNetIncome -16,938,000
7 BaseVar 29,233,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.392
9 EconomicCapitalRatio 1.78

Edgar->Model Mapping

Feature Distribution

Change over Time